Psoriahue

Ciudad Autonoma de Buenos Aire, Buenos Aires C1425DKG

1 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Eczema, Psoriasis

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early